ClinicalTrials.gg
CompletedNCT05564481ROUTE-T1DUpdated Oct 22, 2026Results posted

Research on Optimizing the Use of Technology With Education

An interventional study of diabetes education and parent coaching support in Type 1 Diabetes, Continuous Glucose Monitoring and Behavioral Intervention, sponsored by Children's National Research Institute. Completed at 1 site in United States. Open to participants aged 10 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Children's National Research Institute · Not applicable, Interventional, and Treatment

How we know

Updated Oct 22, 2026Now CompletedResults posted+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
10 Years to 15 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,458 studies in Diabetes Mellitus, Type 1 with a site in United States — 190 open to participants now, 257 under way, 17 of them phase 3. Diabetes Mellitus, Type 1 · United States.

Enrollment
468th of 1,242
60 · median 40
Started
2022
with 61 others
No phase
614 of 1,458
99 open now
Registered
1,194th of 1,458
by date

Among the 1,458 studies in Diabetes Mellitus, Type 1 with a site in United States, this one is the 468th largest by enrollment of the 1,242 interventional ones that give a count, is one of 62 that started in 2022, is one of 614 with no phase, and was the 1,194th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

190 of the 1,458 studies in Diabetes Mellitus, Type 1 with a site in United States are open now. Recruiting first, the newest first:

185 more — sign in →

All 190 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 10 Years to 15 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,458 studies in Diabetes Mellitus, Type 1 with a site in United States, or all of them as a file.
02

Study summary

Consistent use of continuous glucose monitors (CGM) has the potential to improve glycemic control and related type 1 diabetes (T1D) health outcomes, however young adolescents with T1D are the least likely age group to begin and sustain use of CGM. The proposed study will conduct a feasibility trial of a behavioral intervention designed to optimize use of CGM in adolescents specifically targeting underrepresented populations in diabetes technology research.

Read the detailed description

Young adolescents (ages 10-15) with type 1 diabetes (T1D) are at high risk for deterioration of glycemic control and relatedly poor overall T1D self-management. Continuous glucose monitors (CGM) provide real-time indicators of glucose levels and alert users to hypoglycemia and hyperglycemia. Consistent, informed use of CGM has the potential to improve glycemic control and related T1D health outcomes. However, adolescents with T1D are the least likely age group to utilize CGM and significant health disparities exist in access to and use of CGM among youth from racial and ethnic minority backgrounds and youth with public insurance. Adolescent CGM users also continue to evidence A1c levels above recommended targets, potentially due challenges related to perceived CGM burden and related family functioning. Novel, developmentally targeted interventions delivered early in adolescence could promote optimal uptake and use of CGM and reduce psychosocial barriers to sustained use but must be evaluated in rigorous pilot trials that attend to health disparities. The current study proposes to evaluate an innovative behavioral intervention that utilizes certified diabetes care and education specialists (CDCES) to teach problem-solving and communication skills around CGM data and use, targeting adolescent-parent T1D interactions related to glucose data, individualized CGM challenges, and weekly adolescent-parent joint review of CGM reports. The intervention also addresses HCP knowledge of health disparities in diabetes technology through interactive education, and boosts family support through connection with peer parent consultants. This study aims to evaluate the preliminary efficacy of the behavioral intervention to enhance CGM use and resulting T1D health outcomes. Sixty adolescents and their parents (using a dyad study design) will be recruited for this pilot randomized trial, randomly assigned to either an immediate intervention group or a delayed intervention group serving as a standard care comparison. Intervention content will be delivered via 3 telemedicine sessions with adolescents and a parent and supported by connection with a peer parent consultant. Medical and psychosocial data (including A1c, CGM indicators, CGM burdens and benefits, diabetes distress, and diabetes-related family conflict) will be collected from adolescents and a parent at baseline and three follow-up time points across the first year after CGM initiation. The investigators will employ quantitative and qualitative analyses to evaluate intervention feasibility, acceptability, and impact. Enhancing CGM access and use at this key developmental juncture provides an excellent opportunity for tailored support and problem-solving, resulting in potentially lasting improvement in diabetes self-management. Results of this pilot trial will directly inform a multi-site randomized clinical trial to evaluate efficacy, with the long term goal of identifying effective behavioral strategies that can be integrated into routine diabetes education and care.

03

Conditions studied

  • Type 1 Diabetes
  • Continuous Glucose Monitoring
  • Behavioral Intervention
  • Parent-Child Relations
04

Who can participate

Ages eligible
10 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 10-15 years old
  • Type 1 diabetes
  • Type 1 diabetes diagnosis ≥ 6 months \
  • Starting a continuous glucose monitor for the first time or restarting after ≥ 1 year

Exclusion criteria

Exclusion Criteria:

  • Younger than 10, older than 15
  • Diagnosed less than 6 months
  • Already using CGM or has used within last year
  • Other major medical condition such as cancer, cystic fibrosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Immediate intervention

    Participants randomized to the immediate intervention group will participate in 3 video-conferencing sessions with a Certified Diabetes Care and Education Specialist (CDCES) interventionist and connect with a peer parent consultant immediately post randomization (expected intervention duration: 3 months).

    Behavioral: diabetes education and parent coaching support

  • Active comparator
    Wait-list/delayed intervention

    Participants randomized to the delayed intervention group will receive no intervention for 6 months post-randomization; after the 6-month follow-up period, the delayed intervention group also will participate in 3 video conferencing sessions with a CDCES interventionist and connect with a peer parent consultant (expected intervention duration: 3 months).

    Behavioral: diabetes education and parent coaching support

Interventions

  • Behavioraldiabetes education and parent coaching support

    Intervention sessions will include parent/child discussion about barriers to CGM use, review of CGM data, problem solving, and working as a team.

06

What researchers measure

Primary outcomes

  1. Glycemic Control

    Hemoglobin A1c (HbA1c)

    Time frame: 6 months post-randomization

  2. Glycemic Control

    Hemoglobin A1c (HbA1c)

    Time frame: 12 months post-randomization

  3. CGM Time-in-range

    CGM time-in-range is the amount of time a person with diabetes spends in a target glucose range of 70 and 180 mg/dL. The time frame used was 90-day CGM data, with the end date of the 90 days being the 6-month timepoint start date.

    Time frame: 6 months post-randomization

  4. CGM Time-in-range

    CGM time-in-range is the amount of time a person with diabetes spends in a target glucose range of 70 and 180 mg/dL. The time frame used was 90-day CGM data, with the end date of the 90 days being the 12-month timepoint start date.

    Time frame: 12 months post-randomization

  5. CGM Wear-time

    The duration of time that the CGM is worn on the body. The time frame used was 90-day CGM data, with the end date of the 90 days being the 6-month timepoint start date.

    Time frame: 6 months post randomization

  6. CGM Wear-time

    The duration of time that the CGM is worn on the body. The time frame used was 90-day CGM data, with the end date of the 90 days being the 12-month timepoint start date.

    Time frame: 12 months post-randomization

Secondary outcomes

  1. Caregiver-Reported Family Conflict

    The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 6-month caregiver-reported diabetes family conflict is reported here.

    Time frame: 6 months post-randomization

  2. Caregiver-Reported Family Conflict

    The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 12-month caregiver-reported diabetes family conflict is reported here.

    Time frame: 12 months post-randomization

  3. Youth-Reported Family Conflict

    The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 6-month youth-reported diabetes family conflict is reported here.

    Time frame: 6 months post-randomization

  4. Youth-Reported Family Conflict

    The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 12-month youth-reported diabetes family conflict is reported here.

    Time frame: 12 months post-randomization

  5. Caregiver CGM Benefits and Burdens

    The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 6-month caregiver-reported Ben/Bur CGM is reported here.

    Time frame: 6 months post randomization

  6. Caregiver CGM Benefits and Burdens

    The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 12-month caregiver-reported Ben/Bur CGM is reported here.

    Time frame: 12 months post randomization

  7. Youth CGM Benefits and Burdens

    The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 6-month youth-reported Ben/Bur CGM is reported here.

    Time frame: 6 months post randomization

  8. Youth CGM Benefits and Burdens

    The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 12-month youth-reported Ben/Bur CGM is reported here.

    Time frame: 12 months post randomization

  9. Child/Teen Diabetes Distress

    Problem Areas in Diabetes Children (PAID-C) and Teen (PAID-T) versions measure diabetes-specific emotional distress for children and adolescents. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Items are summed to create an overall distress score, with higher scores indicating greater emotional distress. For the PAID-T and PAID-C, higher scores reflect greater diabetes-specific diabetes distress for both teens and children. Scores range from 14-84 for the PAID-T and 11-66 for the PAID-C. To address the unequal sample sizes between the PAID-C (n=19) and PAID-T (n=41), scores were normalized by converting the raw scores into percentages of the maximum possible score for each version. This normalization ensured that both the child and teen versions of the PAID were on the same scale (0-100%), allowing for more accurate comparisons across groups and improving statistical power. Data here is for youth at 6-months.

    Time frame: 6 months post-randomization

  10. Child/Teen Diabetes Distress

    Problem Areas in Diabetes Children (PAID-C) and Teen (PAID-T) versions measure diabetes-specific emotional distress for children and adolescents. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Items are summed to create an overall distress score, with higher scores indicating greater emotional distress. For the PAID-T and PAID-C, higher scores reflect greater diabetes-specific diabetes distress for both teens and children. Scores range from 14-84 for the PAID-T and 11-66 for the PAID-C. To address the unequal sample sizes between the PAID-C (n=19) and PAID-T (n=41), scores were normalized by converting the raw scores into percentages of the maximum possible score for each version. This normalization ensured that both the child and teen versions of the PAID were on the same scale (0-100%), allowing for more accurate comparisons across groups and improving statistical power. 12-month youth date is presented here.

    Time frame: 12 months post-randomization

  11. Caregiver Diabetes Distress

    The Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR) assesses the perceived parental burden associated with caring for a child with diabetes. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Each of the 18 items is reverse scored (0 to 4, 1 to 3, etc.), then you calculate the mean of all non-missing items. That mean is multiplied by 25 to produce a total score ranging from 0 to 100, with higher scores indicating greater parent diabetes-related distress. 6-month caregiver-reported diabetes distress is reported here.

    Time frame: 6 months post-randomization

  12. Caregiver Diabetes Distress

    The Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR) assesses the perceived parental burden associated with caring for a child with diabetes. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Each of the 18 items is reverse scored (0 to 4, 1 to 3, etc.), then you calculate the mean of all non-missing items. That mean is multiplied by 25 to produce a total score ranging from 0 to 100, with higher scores indicating greater parent diabetes-related distress. 12-month caregiver-reported diabetes distress is reported here.

    Time frame: 12 months post-randomization

  13. Caregiver-Reported Diabetes Self-Management

    The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 6-month caregiver-reported Diabetes Self-Management is reported here.

    Time frame: 6 months post-randomization

  14. Caregiver-Reported Diabetes Self-Management

    The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 12-month caregiver-reported Diabetes Self-Management is reported here.

    Time frame: 12 months post-randomization

  15. Youth-Reported Diabetes Self-Management

    The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 6-month youth-reported Diabetes Self-Management is reported here.

    Time frame: 6 months post-randomization

  16. Youth-Reported Diabetes Self-Management

    The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 12-month youth-reported Diabetes Self-Management is reported here.

    Time frame: 12 months post-randomization

07

Results

Posted Oct 22, 2026
Limitations and caveats
Several limitations must also be considered. Our sample size of 60 dyads limited our statistical power, and multiple imputation may not be as robust in smaller samples. Additionally, there was no longer term follow-up period for the delayed group, and further changes may be seen with longer follow-up.

Participant flow

From Sept 2022 to January 2024, research assistants pre-screened potentially eligible dyads using the EHR. Once identified, families were mailed recruitment letters and followed up by email, phone, text, and/or in-clinic to verify eligibility and family interest. If the youth and caregiver met eligibility criteria, the team explained the study in detail and offers ample opportunities to ask questions. Once interest is confirmed, an orientation visit is scheduled to enroll and randomize dyads

Participant flow — Overall Study
MilestoneImmediate InterventionWait-list/Delayed Intervention
Started3129
Completed2929
Not completed20

Outcome measures

PrimaryGlycemic Control

Hemoglobin A1c (HbA1c)

Time frame:
6 months post-randomization
Reported as:
Mean · % of HbA1c
Glycemic Control
% of HbA1cImmediate InterventionWait-list/Delayed Intervention
Glycemic Control10.054 ± 2.00010.338 ± 2.002
PrimaryGlycemic Control

Hemoglobin A1c (HbA1c)

Time frame:
12 months post-randomization
Reported as:
Mean · % of HbA1c
Glycemic Control
% of HbA1cImmediate InterventionWait-list/Delayed Intervention
Glycemic Control9.857 ± 1.9439.838 ± 1.710
PrimaryCGM Time-in-range

CGM time-in-range is the amount of time a person with diabetes spends in a target glucose range of 70 and 180 mg/dL. The time frame used was 90-day CGM data, with the end date of the 90 days being the 6-month timepoint start date.

Time frame:
6 months post-randomization
Reported as:
Mean · % of time in range
CGM Time-in-range
% of time in rangeImmediate InterventionWait-list/Delayed Intervention
CGM Time-in-range31.458 ± 14.91331.750 ± 15.905
PrimaryCGM Time-in-range

CGM time-in-range is the amount of time a person with diabetes spends in a target glucose range of 70 and 180 mg/dL. The time frame used was 90-day CGM data, with the end date of the 90 days being the 12-month timepoint start date.

Time frame:
12 months post-randomization
Reported as:
Mean · % of time in range
CGM Time-in-range
% of time in rangeImmediate InterventionWait-list/Delayed Intervention
CGM Time-in-range31.350 ± 14.24238.100 ± 15.483
PrimaryCGM Wear-time

The duration of time that the CGM is worn on the body. The time frame used was 90-day CGM data, with the end date of the 90 days being the 6-month timepoint start date.

Time frame:
6 months post randomization
Reported as:
Mean · % of wear time
CGM Wear-time
% of wear timeImmediate InterventionWait-list/Delayed Intervention
CGM Wear-time59.266 ± 30.25845.795 ± 26.829
PrimaryCGM Wear-time

The duration of time that the CGM is worn on the body. The time frame used was 90-day CGM data, with the end date of the 90 days being the 12-month timepoint start date.

Time frame:
12 months post-randomization
Reported as:
Mean · % of wear time
CGM Wear-time
% of wear timeImmediate InterventionWait-list/Delayed Intervention
CGM Wear-time54.482 ± 26.24448.331 ± 28.746
SecondaryCaregiver-Reported Family Conflict

The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 6-month caregiver-reported diabetes family conflict is reported here.

Time frame:
6 months post-randomization
Reported as:
Mean · Scores on a scale
Caregiver-Reported Family Conflict
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver-Reported Family Conflict27.407 ± 8.10228.040 ± 8.507
SecondaryCaregiver-Reported Family Conflict

The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 12-month caregiver-reported diabetes family conflict is reported here.

Time frame:
12 months post-randomization
Reported as:
Mean · Scores on a scale
Caregiver-Reported Family Conflict
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver-Reported Family Conflict26.357 ± 6.95126.591 ± 7.854
SecondaryYouth-Reported Family Conflict

The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 6-month youth-reported diabetes family conflict is reported here.

Time frame:
6 months post-randomization
Reported as:
Mean · Scores on a scale
Youth-Reported Family Conflict
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Youth-Reported Family Conflict28.308 ± 9.19027.480 ± 8.549
SecondaryYouth-Reported Family Conflict

The Diabetes Family Conflict Scale-Revised (DFCS-R) was used to measure diabetes-related family conflict. Total scores are reported below. The DFCS-R is on a scale of 19-57, where a higher score indicates higher family conflict. 12-month youth-reported diabetes family conflict is reported here.

Time frame:
12 months post-randomization
Reported as:
Mean · Scores on a scale
Youth-Reported Family Conflict
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Youth-Reported Family Conflict28.538 ± 9.67223.952 ± 5.945
SecondaryCaregiver CGM Benefits and Burdens

The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 6-month caregiver-reported Ben/Bur CGM is reported here.

Time frame:
6 months post randomization
Reported as:
Mean · Scores on a scale
Caregiver CGM Benefits and Burdens
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver Benefits of CGM Use4.380 ± 1.0824.660 ± 0.467
Caregiver Burdens of CGM Use1.856 ± 0.4071.868 ± 0.561
SecondaryCaregiver CGM Benefits and Burdens

The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 12-month caregiver-reported Ben/Bur CGM is reported here.

Time frame:
12 months post randomization
Reported as:
Mean · Scores on a scale
Caregiver CGM Benefits and Burdens
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver Benefits of CGM Use4.513 ± 0.8384.696 ± 0.479
Caregiver Burdens of CGM Use2.036 ± 0.7301.886 ± 0.925
SecondaryYouth CGM Benefits and Burdens

The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 6-month youth-reported Ben/Bur CGM is reported here.

Time frame:
6 months post randomization
Reported as:
Mean · Scores on a scale
Youth CGM Benefits and Burdens
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Youth Benefits of CGM Use4.282 ± 0.3884.390 ± 0.478
Youth Burdens of CGM Use2.153 ± 0.5222.050 ± 0.621
SecondaryYouth CGM Benefits and Burdens

The Benefits and Burdens of CGM (Ben/Bur CGM) questionnaire includes two 8-item scales (benefits, burdens) that provide important patient-reported outcome metrics to further understand complex behaviors related to adherence to CGM use and diabetes self-management. Each questionnaire (benefits, burdens) contains eight items which are rated on a Likert scale, one to five. 1 is strongly disagree and 5 is strongly agree. Mean total scores for each scale as well as mean scores for each item may be analyzed. Scores range from 1-5 for each item/subscale and for the overall score. Higher mean score on the benefits scale indicates higher perceived benefits while higher mean scores on the burdens scales indicated higher perceived burdens. 12-month youth-reported Ben/Bur CGM is reported here.

Time frame:
12 months post randomization
Reported as:
Mean · Scores on a scale
Youth CGM Benefits and Burdens
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Youth Benefits of CGM Use4.317 ± 0.5004.631 ± 0.404
Youth Burdens of CGM Use2.163 ± 0.7622.000 ± 0.647
SecondaryChild/Teen Diabetes Distress

Problem Areas in Diabetes Children (PAID-C) and Teen (PAID-T) versions measure diabetes-specific emotional distress for children and adolescents. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Items are summed to create an overall distress score, with higher scores indicating greater emotional distress. For the PAID-T and PAID-C, higher scores reflect greater diabetes-specific diabetes distress for both teens and children. Scores range from 14-84 for the PAID-T and 11-66 for the PAID-C. To address the unequal sample sizes between the PAID-C (n=19) and PAID-T (n=41), scores were normalized by converting the raw scores into percentages of the maximum possible score for each version. This normalization ensured that both the child and teen versions of the PAID were on the same scale (0-100%), allowing for more accurate comparisons across groups and improving statistical power. Data here is for youth at 6-months.

Time frame:
6 months post-randomization
Reported as:
Mean · Scores on a scale
Child/Teen Diabetes Distress
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Child/Teen Diabetes Distress48.160 ± 19.61642.658 ± 20.632
SecondaryChild/Teen Diabetes Distress

Problem Areas in Diabetes Children (PAID-C) and Teen (PAID-T) versions measure diabetes-specific emotional distress for children and adolescents. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Items are summed to create an overall distress score, with higher scores indicating greater emotional distress. For the PAID-T and PAID-C, higher scores reflect greater diabetes-specific diabetes distress for both teens and children. Scores range from 14-84 for the PAID-T and 11-66 for the PAID-C. To address the unequal sample sizes between the PAID-C (n=19) and PAID-T (n=41), scores were normalized by converting the raw scores into percentages of the maximum possible score for each version. This normalization ensured that both the child and teen versions of the PAID were on the same scale (0-100%), allowing for more accurate comparisons across groups and improving statistical power. 12-month youth date is presented here.

Time frame:
12 months post-randomization
Reported as:
Mean · Scores on a scale
Child/Teen Diabetes Distress
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Child/Teen Diabetes Distress45.504 ± 21.61540.590 ± 20.895
SecondaryCaregiver Diabetes Distress

The Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR) assesses the perceived parental burden associated with caring for a child with diabetes. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Each of the 18 items is reverse scored (0 to 4, 1 to 3, etc.), then you calculate the mean of all non-missing items. That mean is multiplied by 25 to produce a total score ranging from 0 to 100, with higher scores indicating greater parent diabetes-related distress. 6-month caregiver-reported diabetes distress is reported here.

Time frame:
6 months post-randomization
Reported as:
Mean · Scores on a scale
Caregiver Diabetes Distress
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver Diabetes Distress40.093 ± 22.98842.035 ± 22.635
SecondaryCaregiver Diabetes Distress

The Problem Areas in Diabetes Survey - Parent Revised version (PAID-PR) assesses the perceived parental burden associated with caring for a child with diabetes. Responses target how much each diabetes-related experience bothers/upsets the individual respondent over the past month. Each of the 18 items is reverse scored (0 to 4, 1 to 3, etc.), then you calculate the mean of all non-missing items. That mean is multiplied by 25 to produce a total score ranging from 0 to 100, with higher scores indicating greater parent diabetes-related distress. 12-month caregiver-reported diabetes distress is reported here.

Time frame:
12 months post-randomization
Reported as:
Mean · Scores on a scale
Caregiver Diabetes Distress
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver Diabetes Distress41.404 ± 20.51839.962 ± 24.472
SecondaryCaregiver-Reported Diabetes Self-Management

The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 6-month caregiver-reported Diabetes Self-Management is reported here.

Time frame:
6 months post-randomization
Reported as:
Mean · Scores on a scale
Caregiver-Reported Diabetes Self-Management
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver-Reported Diabetes Self-Management75.638 ± 11.50478.395 ± 14.409
SecondaryCaregiver-Reported Diabetes Self-Management

The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 12-month caregiver-reported Diabetes Self-Management is reported here.

Time frame:
12 months post-randomization
Reported as:
Mean · Scores on a scale
Caregiver-Reported Diabetes Self-Management
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Caregiver-Reported Diabetes Self-Management76.581 ± 10.46478.287 ± 14.308
SecondaryYouth-Reported Diabetes Self-Management

The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 6-month youth-reported Diabetes Self-Management is reported here.

Time frame:
6 months post-randomization
Reported as:
Mean · Scores on a scale
Youth-Reported Diabetes Self-Management
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Youth-Reported Diabetes Self-Management72.630 ± 11.53174.810 ± 14.880
SecondaryYouth-Reported Diabetes Self-Management

The Diabetes Management Questionnaire (DMQ)-a self- and parent-report measure assessing the frequency of engagement in diabetes care behaviors (e.g. BG monitoring, adjusting behavior to specific situations) over the past month. Scored 0-100 with higher scores indicating higher adherence to diabetes management. 12-month youth-reported Diabetes Self-Management is reported here.

Time frame:
12 months post-randomization
Reported as:
Mean · Scores on a scale
Youth-Reported Diabetes Self-Management
Scores on a scaleImmediate InterventionWait-list/Delayed Intervention
Youth-Reported Diabetes Self-Management77.258 ± 12.50180.968 ± 12.686

Adverse events

Collected over From the date of enrollment until the end of the follow-up period at 12 months post-randomization.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Immediate Intervention - Youth0/31 (0%)0/31 (0%)0/31 (0%)
Wait-list/Delayed Intervention: Intervention - Youth0/29 (0%)0/29 (0%)0/29 (0%)
Immediate Intervention - Caregivers0/31 (0%)0/31 (0%)0/31 (0%)
Wait-list/Delayed Intervention: Intervention - Caregivers0/29 (0%)0/29 (0%)0/29 (0%)

Baseline characteristics

The immediate intervention had 31 dyads (31 youth, 31 caregivers) totaling 62 participants. The delayed intervention had 29 dyads (29 youth, 29 caregivers) totaling 58 participants. This is a total of 60 dyads (120 individual participants).

Age, Categorical
Age, Categorical(Participants)Immediate InterventionWait-list/Delayed InterventionTotal
Youth Age — <=18 years312960
Youth Age — Between 18 and 65 years000
Youth Age — >=65 years000
Caregiver Age — <=18 years000
Caregiver Age — Between 18 and 65 years312960
Caregiver Age — >=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Immediate InterventionWait-list/Delayed InterventionTotal
Youth Sex — Female111425
Youth Sex — Male201535
Caregiver Sex — Female252651
Caregiver Sex — Male639
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Immediate InterventionWait-list/Delayed InterventionTotal
Youth Race/Ethnicity — Black, non-Hispanic171532
Youth Race/Ethnicity — Hispanic/Latine8816
Youth Race/Ethnicity — White, non-Hispanic325
Youth Race/Ethnicity — Another racially minoritized identity347
Caregiver Race/Ethnicity — Black, non-Hispanic161329
Caregiver Race/Ethnicity — Hispanic/Latine7815
Caregiver Race/Ethnicity — White, non-Hispanic459
Caregiver Race/Ethnicity — Another racially minoritized identity437
Benefits and Burdens of CGM Use
Benefits and Burdens of CGM Use(Points)Immediate InterventionWait-list/Delayed InterventionTotal
Benefits of CGM Use - Caregiver4.484 ± 0.7284.224 ± 1.1694.358 ± 0.967
Burdens of CGM Use - Caregiver1.995 ± 0.7341.825 ± 0.5421.913 ± 0.649
Benefits of CGM Use - Youth4.236 ± 0.5974.338 ± 0.6174.285 ± 0.604
Burdens of CGM Use - Youth1.968 ± 0.6961.990 ± 0.5261.979 ± 0.615
Problem Areas in Diabetes Scale (PAID)
Problem Areas in Diabetes Scale (PAID)(Points)Immediate InterventionWait-list/Delayed InterventionTotal
PAID-T (teen)36.905 ± 15.04634.053 ± 15.38935.561 ± 14.893
PAID-C (child)27.670 ± 15.22034.867 ± 13.25131.079 ± 14.404
PAID-PR (parent)55.968 ± 20.62545.284 ± 19.20250.975 ± 20.343
Diabetes Family Conflict Scale
Diabetes Family Conflict Scale(Points)Immediate InterventionWait-list/Delayed InterventionTotal
DFCS Caregiver32.581 ± 10.14528.000 ± 6.17630.300 ± 8.701
DFCS Youth28.467 ± 8.55329.107 ± 8.80028.746 ± 8.531
Diabetes Management Questionnaire
Diabetes Management Questionnaire(Points)Immediate InterventionWait-list/Delayed InterventionTotal
DMQ Caregiver75.521 ± 10.83978.967 ± 11.50677.187 ± 11.206
DMQ Youth76.628 ± 9.11676.602 ± 13.11976.615 ± 11.133
HbA1c
HbA1c(% of HbA1c)Immediate InterventionWait-list/Delayed InterventionTotal
Mean10.7 ± 2.210.5 ± 1.910.6 ± 2.0

9 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Children's National Research Institute
    Washington D.C., District of Columbia 20010, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Jan 2025, 27 months.

Results were first posted in Oct 2026, 1 year 9 months after primary completion.

Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's 27 months is above that.

Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: start Jan 2022 → Sep 2022 and completion Dec 2026 → Jan 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2022
First posted
Oct 3, 2022
StartActual
Sep 7, 2022was Jan 2022
Primary completionActual
Jan 1, 2025
CompletionActual
Jan 1, 2025was Dec 2026
Results first posted
Oct 22, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 22, 2026
Results
Results posted
posted Oct 22, 2026
Start date
Jan 1, 2022→Sep 7, 2022
Oct 22, 2026
Study completion
Dec 1, 2026→Jan 1, 2025 (actual)
Oct 22, 2026
Primary outcomes
2 edited, 4 added, 6 removed
What changed in the outcomes
  • EditedGlycemic controlControlTime frame: Baseline → 6 months post-randomization
  • EditedGlycemic controlControlTime frame: 3 months post randomization → 12 months post-randomization
  • AddedCGM Time-in-rangeTime frame: 6 months post-randomization
  • AddedCGM Time-in-rangeTime frame: 12 months post-randomization
  • AddedCGM Wear-timeTime frame: 6 months post randomization
  • AddedCGM Wear-timeTime frame: 12 months post-randomization
  • RemovedGlycemic controlTime frame: 6 months post randomization
  • RemovedGlycemic controlTime frame: 12 months post randomization
  • Removedglycemic variabilityTime frame: Baseline
  • Removedglycemic variabilityTime frame: 3 months post randomization
  • Removedglycemic variabilityTime frame: 6 months post randomization
  • Removedglycemic variabilityTime frame: 12 months post randomization
Oct 22, 2026
Secondary outcomes
16 edited, 4 removed
What changed in the outcomes
  • EditedCaregiver-Reported Family ConflictTime frame: Baseline → 6 months post-randomization
  • EditedCaregiver-Reported Family ConflictTime frame: 3 months post randomization → 12 months post-randomization
  • EditedYouth-Reported Family ConflictTime frame: 6 months post randomization → 6 months post-randomization
  • EditedYouth-Reported Family ConflictTime frame: 12 months post randomization → 12 months post-randomization
  • EditedChild/Teen Diabetes DistressTime frame: Baseline → 6 months post-randomization
  • EditedChild/Teen Diabetes DistressTime frame: 3 months post randomization → 12 months post-randomization
  • EditedCaregiver Diabetes DistressTime frame: 6 months post randomization → 6 months post-randomization
  • EditedCaregiver Diabetes DistressTime frame: 12 months post randomization → 12 months post-randomization
  • EditedCaregiver CGM benefitsBenefits and burdensBurdensTime frame: Baseline → 6 months post randomization
  • EditedCaregiver CGM benefitsBenefits and burdensBurdensTime frame: 3 months post randomization → 12 months post randomization
  • EditedYouth CGM benefitsBenefits and burdensBurdensTime frame: 6 months post randomization
  • EditedYouth CGM benefitsBenefits and burdensBurdensTime frame: 12 month post randomization → 12 months post randomization
  • EditedCaregiver-Reported Diabetes selfSelf-managementManagementTime frame: Baseline → 6 months post-randomization
  • EditedCaregiver-Reported Diabetes selfSelf-managementManagementTime frame: 3 months post randomization → 12 months post-randomization
  • EditedYouth-Reported Diabetes selfSelf-managementManagementTime frame: 6 months post randomization → 6 months post-randomization
  • EditedYouth-Reported Diabetes selfSelf-managementManagementTime frame: 12 months post randomization → 12 months post-randomization
  • RemovedCGM useTime frame: Baseline
  • RemovedCGM useTime frame: 3 months post randomization
  • RemovedCGM useTime frame: 6 months post randomization
  • RemovedCGM useTime frame: 12 months post randomization
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Active, not recruiting→Completed
    Results posted
    Start date Jan 1, 2022→Sep 7, 2022
    Study completion Dec 1, 2026→Jan 1, 2025 (now actual)
    Primary outcomes 2 edited, 4 added, 6 removed
    What changed in the outcomes
    • EditedGlycemic controlControlTime frame: Baseline → 6 months post-randomization
    • EditedGlycemic controlControlTime frame: 3 months post randomization → 12 months post-randomization
    • AddedCGM Time-in-rangeTime frame: 6 months post-randomization
    • AddedCGM Time-in-rangeTime frame: 12 months post-randomization
    • AddedCGM Wear-timeTime frame: 6 months post randomization
    • AddedCGM Wear-timeTime frame: 12 months post-randomization
    • RemovedGlycemic controlTime frame: 6 months post randomization
    • RemovedGlycemic controlTime frame: 12 months post randomization
    • Removedglycemic variabilityTime frame: Baseline
    • Removedglycemic variabilityTime frame: 3 months post randomization
    • Removedglycemic variabilityTime frame: 6 months post randomization
    • Removedglycemic variabilityTime frame: 12 months post randomization
    Secondary outcomes 16 edited, 4 removed
    What changed in the outcomes
    • EditedCaregiver-Reported Family ConflictTime frame: Baseline → 6 months post-randomization
    • EditedCaregiver-Reported Family ConflictTime frame: 3 months post randomization → 12 months post-randomization
    • EditedYouth-Reported Family ConflictTime frame: 6 months post randomization → 6 months post-randomization
    • EditedYouth-Reported Family ConflictTime frame: 12 months post randomization → 12 months post-randomization
    • EditedChild/Teen Diabetes DistressTime frame: Baseline → 6 months post-randomization
    • EditedChild/Teen Diabetes DistressTime frame: 3 months post randomization → 12 months post-randomization
    • EditedCaregiver Diabetes DistressTime frame: 6 months post randomization → 6 months post-randomization
    • EditedCaregiver Diabetes DistressTime frame: 12 months post randomization → 12 months post-randomization
    • EditedCaregiver CGM benefitsBenefits and burdensBurdensTime frame: Baseline → 6 months post randomization
    • EditedCaregiver CGM benefitsBenefits and burdensBurdensTime frame: 3 months post randomization → 12 months post randomization
    • EditedYouth CGM benefitsBenefits and burdensBurdensTime frame: 6 months post randomization
    • EditedYouth CGM benefitsBenefits and burdensBurdensTime frame: 12 month post randomization → 12 months post randomization
    • EditedCaregiver-Reported Diabetes selfSelf-managementManagementTime frame: Baseline → 6 months post-randomization
    • EditedCaregiver-Reported Diabetes selfSelf-managementManagementTime frame: 3 months post randomization → 12 months post-randomization
    • EditedYouth-Reported Diabetes selfSelf-managementManagementTime frame: 6 months post randomization → 6 months post-randomization
    • EditedYouth-Reported Diabetes selfSelf-managementManagementTime frame: 12 months post randomization → 12 months post-randomization
    • RemovedCGM useTime frame: Baseline
    • RemovedCGM useTime frame: 3 months post randomization
    • RemovedCGM useTime frame: 6 months post randomization
    • RemovedCGM useTime frame: 12 months post randomization
    + 6 other changes: verification date, oversight details, description, design details, index terms and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05564481
Responsible party
Randi Streisand (Chief of Psych/Behavioral Hlth, Children's National Research Institute) — Principal investigator
First posted
Oct 3, 2022
Start date
Sep 7, 2022
Primary completion
Jan 1, 2025
Completion
Jan 1, 2025
Results posted
Oct 22, 2026
Last update
Oct 22, 2026

Study contacts

Randi Streisand, PhD
principal investigator · Children's National Hosptial

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion